Avanos Medical at JP Morgan conference; no specific financial metrics disclosed in available text

AVANOS MEDICAL, INC.

Presentation by Interim CEO Michael Greiner at 43rd Annual JP Morgan Healthcare Conference on January 13, 2025.
Exhibit text is truncated; only introductory remarks are visible, no numerical results or guidance provided.
No changes to previously disclosed business plans or objectives were noted in the incomplete text.
Filing is under Regulation FD; presentation is furnished, not filed, per standard practice.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.